ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
69 024,46
0,72%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Travere Therapeutics Inc (TVTX)

  7. Travere Therapeutics Inc (TVTX) Actualités

TVTX Travere Therapeutics Inc

5,90
-0,44 (-6,94%)
25 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Travere Therapeutics Inc TVTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,44 -6,94% 5,90 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,35 6,14 6,39 6,16 6,34
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
15/5/202423:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
13/5/202422:05EDGAR2Form 8-K - Current report
10/5/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:30GLOBETravere Therapeutics to Present at National Kidney..
08/5/202422:30GLOBETravere Therapeutics to Present at Upcoming Investor..
06/5/202422:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:05EDGAR2Form 8-K - Current report
06/5/202422:01GLOBETravere Therapeutics Reports First Quarter 2024 Financial..
29/4/202422:30GLOBETravere Therapeutics to Report First Quarter 2024 Financial..
24/4/202413:05GLOBETravere Therapeutics and CSL Vifor Announce European..
24/4/202409:00PRNCACSL Vifor and Travere Therapeutics Announce European..
04/4/202422:30GLOBETravere Therapeutics to Present Abstracts at the Society for..
03/4/202422:30GLOBETravere Therapeutics to Present Abstracts on FILSPARI®..
13/3/202422:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
11/3/202412:05GLOBETravere Therapeutics Submits Supplemental New Drug..
26/2/202422:30GLOBETravere Therapeutics to Present at Upcoming Investor..
23/2/202422:05EDGAR2Form 8-K - Current report
23/2/202413:05GLOBETravere Therapeutics and CSL Vifor Announce Sparsentan..
23/2/202408:00PRNCACSL Vifor and Travere Therapeutics announce sparsentan..
20/2/202414:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202422:05EDGAR2Form 8-K - Current report
15/2/202422:01GLOBETravere Therapeutics Reports Fourth Quarter and Full Year..
14/2/202420:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:30GLOBETravere Therapeutics to Report Fourth Quarter and Full Year..
02/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202403:58EDGAR2Form 144 - Report of proposed sale of securities
02/2/202403:58EDGAR2Form 144 - Report of proposed sale of securities
02/2/202403:57EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:30GLOBETravere Therapeutics to Present at the Guggenheim 6th Annual..
01/2/202418:44EDGAR2Form 144 - Report of proposed sale of securities
01/2/202415:52EDGAR2Form 144 - Report of proposed sale of securities
25/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:05GLOBETravere Therapeutics Announces Licensing Agreement with..
23/1/202419:17EDGAR2Form 144 - Report of proposed sale of securities
23/1/202416:51EDGAR2Form 144 - Report of proposed sale of securities
08/1/202413:07EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
TVTX
Travere Therapeutics
BIT
P1Z307
NLBNPIT1Z307 20991231 47...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés